Dermatology Therapies
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
120
NCT05636904
Safety and Efficacy Study of Topical DLQ01 in the Treatment of Androgenetic Alopecia (AGA) in Men
Phase: Phase 1/2
Role: Lead Sponsor
Start: Dec 5, 2022
Completion: Mar 28, 2024
Loading map...